PRELUDE CAPITAL MANAGEMENT, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$538,293
-9.6%
15,758
+1.8%
0.04%
-10.3%
Q2 2023$595,672
-24.4%
15,472
-29.7%
0.04%
-17.0%
Q1 2023$787,809
+56.5%
22,012
+72.4%
0.05%
+80.8%
Q4 2022$503,482
+25074.1%
12,769
+1630.2%
0.03%
Q2 2017$2,000
-99.3%
738
-97.9%
0.00%
-100.0%
Q4 2016$269,000
+796.7%
34,928
+1243.4%
0.03%
+725.0%
Q2 2015$30,000
+76.5%
2,600
+160.0%
0.00%
+100.0%
Q1 2015$17,0001,0000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders